PLX Competitors & Alternatives

Compare Protalix Biotherapeutics Inc with similar stocks in the same industry

Biotechnology

PLX

Main Stock
$2.31
Tradestie Score
64
Market Cap
$188.17M
P/E Ratio
12.8
Revenue Growth
2.3%
Analyst Upside
+376.2%

Top Competitors

233 stocks in Biotechnology
Company Price Market Cap P/E Score Action
VTYX Ventyx Biosciences, Inc. Common Stock
$14.00
$256.71M - 53 Compare
NGNE Neurogene, Inc. Common Stock
$39.08
$256.54M - 62 Compare
SLS SELLAS Life Sciences Group, Inc. Common Stock
$13.39
$211.22M - 54 Compare
ACRS Aclaris Therapeutics, Inc.
$5.43
$202.58M - 63 Compare
ASMB Assembly Biosciences, Inc
$26.76
$188.81M 342.5 57 Compare
FBRX Forte Biosciences, Inc. Common Stock
$43.20
$180.53M - 56 Compare
AVTX Avalo Therapeutics, Inc. Common Stock
$18.42
$170.45M - 61 Compare
ACHV Achieve Life Sciences, Inc.
$6.31
$158.43M - 57 Compare
NVCT Nuvectis Pharma, Inc. Common Stock
$18.29
$154.27M - 51 Compare
CLYM Climb Bio, Inc. Common Stock
$13.24
$133.50M - 59 Compare

Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)

233 stocks in this industry